Name (Synonyms) | Correlation | |
---|---|---|
drug1767 | Passed infection of SARS-CoV-2 Wiki | 1.00 |
Name (Synonyms) | Correlation | |
---|---|---|
D018376 | Cardiovascular Abnormalities NIH | 1.00 |
D006330 | Heart Defects, Congenital NIH | 0.71 |
D009205 | Myocarditis NIH | 0.38 |
D018352 | Coronavirus Infections NIH | 0.04 |
Name (Synonyms) | Correlation | |
---|---|---|
HP:0001627 | Abnormal heart morphology HPO | 0.71 |
HP:0012819 | Myocarditis HPO | 0.38 |
HP:0001626 | Abnormality of the cardiovascular system HPO | 0.21 |
There is one clinical trial.
This study will be conducted as a registry to identify asymptomatic or symptomatic persons to determine whether they carry SARS-CoV-2 antibodies.
Description: To evaluate the prevalence of COVID-19 exposure to healthcare staff, community 1st responders and patients. and patient population within a subspecialty
Measure: prevalence of COVID-19 exposure Time: Mar-Dec 2020Description: correlation between the test results with the presence or lack of COVID-19 symptoms or illness
Measure: correlation between the test results with the presence or lack of COVID-19 symptoms or illness Time: Mar-Dec 2020Description: correlate pre-existing risk factors with test results and baseline symptoms
Measure: correlate pre-existing risk factors with test results and baseline symptoms Time: Mar-Dec 2020Description: correlate subsequent healthcare utilization with test results and baseline symptoms
Measure: correlate subsequent healthcare utilization with test results and baseline symptoms Time: Mar-Dec 2020